Neal is a partner in Wiley's Intellectual Property Group, where he leads the Patent Litigation Practice. He is a past member of the firm’s Management Committee and currently serves as co-chair of the Diversity, Equity, and Inclusion Committee. He concentrates his practice on intellectual property and commercial matters.
Pharmaceutical Patent Litigation
Neal has extensive experience as lead counsel litigating pharmaceutical patent matters, including Hatch-Waxman/ANDA litigation and inter partes reviews (IPRs). Notable cases concerned the following products:
• apixaban (Eliquis®)
• lurasidone (Latuda®)
• aripiprazole (Abilify®)
• lenalidomide (Revlimid®)
• bendamustine (Treanda®)
• olanzapine (Zyprexa®)
• brexpiprazole (Rexulti®)
• pomalidomide (Pomalyst®)
• cinacalcet (Sensipar®)
• rivaroxaban (Xarelto®)
• colchicine (Colcrys®)
• roflumilast (Daliresp®)
• dexmedetomidine (Precedex®)
• sacubitril/valsartan (Entresto®)
• diclofenac (Solaraze®)
• sitagliptin (Januvia®, Janumet®)
• esomeprazole (Nexium®)
• tenofovir alafenamide (Descovy®)
• fesoterodine (Toviaz®)
• vortioxetine (Trintellix®)
• leuprolide acetate (Eligard®)
Neal also has significant experience handling a wide variety of FDA regulatory matters usually adjacent to pertinent Hatch-Waxman/ANDA litigation issues, as well as general corporate counseling for pharmaceutical companies concerning commercial matters.
- Lead counsel for defendant in patent litigation concerning aluminum alloys. Rio Tinto Alcan Intl. Ltd et al. v Century Aluminum Co., No. 19-829 (D. Del.)
- Lead counsel for defendant in winning full dismissal of product liability claims concerning generic minocycline. Johnson v. Novartis Pharms. Corp. et al., No. 5:19-cv-01087 (W.D. Tex. 2020).
- Represented defendant in connection with the valsartan product liability multidistrict litigation. In re Valsartan N-Nitrosodimethylamine (NDMA) Contamination Products Liability Litigation, No. 19-2875 (D.N.J. 2019)
- Lead counsel for defendant in securing full dismissal of product liability claims concerning generic escitalopram (Lexapro®). Patton v. Forrest Labs. et al., No. 5:17-cv-0922 (C.D. Cal. 2018).
- Lead counsel for defendants in a patent infringement litigation concerning robotic gripping fingers. GMG Gesellschaft Fur Modulare Greifersysteme mbH et al. v. Robotiq, Inc. et al., No. 2:16-cv-573 (E.D.Va. 2017).
- Represented appellants in the U.S. Court of Appeals for the Federal Circuit in successfully reversing the district court’s summary judgment of no infringement. 01 Communique Laboratory, Inc. v. LogMeIn, Inc., 687 F. 3d 1292 (Fed. Cir. 2012).
- Lead counsel for the defendant accused of infringing patents relating to visual voicemail. Case settled favorably. Brandywine Communications Technologies, LLC v. LG Electronics, Inc., 6:12-cv-00271 (M.D. Fla. 2012).
- Represented two respondents through trial in defending against allegations of patent infringement relating to three patents covering computer forensic devices. Prevailed on an Initial Determination finding no domestic industry. In the Matter of Certain Computer Forensic Devices and Products, 337-TA-799 (2012).
- Represented complainant in a patent infringement action relating to baby strollers and playards. Case settled favorably while summary determination motions were pending. In the Matter of Certain Strollers and Playards, Inv. No. 337-TA-762 (2011).
- Represented complainant as lead counsel in a U.S. International Trade Commission patent infringement action relating to hand-held underground cable and pipe locators. The parties reached a global settlement during the investigation. In the Matter of Certain Underground Cable and Pipe Locators, 337-TA-727 (2010).
- Argued and won a reversal of the Trademark Trial and Appeal Board’s (TTAB) canceling the mark at issue. Precedent-setting case confirmed that a mark’s prosecution file history is automatically of record in an inter partes board proceeding and clarified the burdens of proof in a validity-based trademark cancellation proceeding. The Cold War Museum Inc. v. Cold War Air Museum Inc., 586 F.3d 1352 (Fed. Cir. 2009).
- Represented appellees in the U.S. Court of Appeals for the Federal Circuit’s affirming of the district court ruling on non-infringement and invalidity of patents covering aspects of wrinkle-free shirt seams. TALtech Ltd. v. Esquel Apparel, Inc., 279 Fed. Appx. 974 (Fed. Cir. 2008).
- Represented respondents accused of infringing design patents covering aspects of the Ford F-150. In the Matter of Certain Automotive Parts, Inv. No. 337-TA-557 (2008).
- U.S. Council for International Business
- Co-Chair, Patents Working Group
- American Bar Association (ABA), Section of International Law, India Committee
- Indo-American Chamber of Commerce (IACC)
- Former Chair, Intellectual Property Section, Indo-American Lawyers Council
- North American South Asian Bar Association (NASABA)
- Former Vice-President, Executive Committee
- South Asian Bar Association of Washington, DC (SABA-DC)
- Former President
- Named one of Bisnow’s “Top 40 Lawyers Under 40,” which recognizes up-and-coming lawyers from the Washington, DC metro area who have distinguished themselves with exceptional performance and potential (2016)
- Named one of DC’s “Super Lawyers” for Intellectual Property Litigation by Super Lawyers magazine (2014)
J.D., The George Washington University Law School
B.S., Cornell University
Bar and Court Memberships
- District of Columbia Bar
- Supreme Court of the United States
- U.S. Courts of Appeals for the Fourth and Federal Circuits
- U.S. District Court for the Eastern District of Virginia
- U.S. Patent and Trademark Office
Related News & Insights
- Media MentionNeal Seth Provides Insights on the Significance of an FDA Warning LetterCBS MoneyWatchFebruary 14, 2019
- EventThe New Political Fight – Resolving America’s Drug Pricing Crisis with Patent LawNAPABANovember 9, 2018
- AlertFederal Circuit Patent Bulletin: BASF Corp. v. Johnson Matthey Inc.Lawrence M. Sung, Neal SethDecember 14, 2017
- AlertFederal Circuit Patent Bulletin: Promega Corp. v. Life Techs. Corp.Lawrence M. Sung, Neal SethDecember 12, 2017